Home > Income Statement > CONCORD DRUGS

CONCORD DRUGS
Revenue

    Back to Income Statement
CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Net Sales ₹45 Cr₹45 Cr₹52 Cr₹59 Cr

What is the latest Revenue of CONCORD DRUGS ?

The latest Revenue ratio of CONCORD DRUGS is ₹45 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹45 Cr
Mar2024₹45 Cr
Mar2023₹52 Cr
Mar2022₹59 Cr

How is Revenue of CONCORD DRUGS Trending?

Years Revenue % Change
Mar2025 ₹45 Cr
0.71
Mar2024 ₹45 Cr
-13.74
Mar2023 ₹52 Cr
-11.66
Mar2022 ₹59 Cr -

Compare Revenue of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹106.8 Cr 0.1% 9.3% 22.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,236.0 Cr -1.8% -3.7% 17.2% Stock Analytics
DIVIS LABORATORIES ₹249,673.0 Cr 3.4% 10.1% 57.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,460.0 Cr 1.6% 0.8% 37.8% Stock Analytics
CIPLA ₹111,484.0 Cr -0.4% -5.6% -11.9% Stock Analytics
DR REDDYS LABORATORIES ₹95,220.3 Cr -1.1% -4.9% -9.9% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

0.1%

9.3%

22.1%

SENSEX

-1.6%

-4.2%

-7.2%


You may also like the below Video Courses